Literature DB >> 10092203

CDK9 (PITALRE): a multifunctional cdc2-related kinase.

G de Falco1, A Giordano.   

Abstract

CDK9 is a cdc2-related kinase protein. Previously named PITALRE, this protein is a serine-threonine kinase involved in many physiological processes. Unlike most of the cdc2-like kinases, its activity is not cell cycle-regulated. CDK9 acts preferentially in processes different from cell-cycle regulation, such as differentiation. Its cyclin partners, cyclins of T family, recently have been isolated. CDK9 immunoprecipitates with several unidentified polypeptides that may regulate its kinase activity. CDK9 has been shown to associate with the HIV-Tat protein, suggesting a possible involvement in AIDS. CDK9 recently was shown to be responsible for the kinase activity associated with the TAK complex and with the P-TEFb complex, suggesting activity also in the transcription process.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10092203     DOI: 10.1002/(SICI)1097-4652(199812)177:4<501::AID-JCP1>3.0.CO;2-4

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  17 in total

Review 1.  CDK-related protein kinases in plants.

Authors:  J Joubès; C Chevalier; D Dudits; E Heberle-Bors; D Inzé; M Umeda; J P Renaudin
Journal:  Plant Mol Biol       Date:  2000-08       Impact factor: 4.076

2.  Regulation of P-TEFb elongation complex activity by CDK9 acetylation.

Authors:  Junjiang Fu; Ho-Geun Yoon; Jun Qin; Jiemin Wong
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

Review 3.  PROTACs: great opportunities for academia and industry.

Authors:  Xiuyun Sun; Hongying Gao; Yiqing Yang; Ming He; Yue Wu; Yugang Song; Yan Tong; Yu Rao
Journal:  Signal Transduct Target Ther       Date:  2019-12-24

4.  Downregulation of microRNA-142-3p and its tumor suppressor role in gastric cancer.

Authors:  Yi Wang; Zhidong Cao; Lanlan Wang; Siqi Liu; Jianqiang Cai
Journal:  Oncol Lett       Date:  2018-03-23       Impact factor: 2.967

5.  Cell death induction in resting lymphocytes by pan-Cdk inhibitor, but not by Cdk4/6 selective inhibitor.

Authors:  Makiko Kobayashi; Ikuko Takahashi-Suzuki; Toshiyasu Shimomura; Yoshikazu Iwasawa; Hiroshi Hirai
Journal:  Invest New Drugs       Date:  2010-06-04       Impact factor: 3.850

6.  Evaluation of cyclin D1 expression and its subcellular distribution in mouse tissues.

Authors:  Maria De Falco; Valentina Fedele; Luca De Luca; Roberta Penta; Giuliano Cottone; Ivan Cavallotti; Vincenza Laforgia; Antonio De Luca
Journal:  J Anat       Date:  2004-11       Impact factor: 2.610

7.  Discovery of novel 5-fluoro-N2,N4-diphenylpyrimidine-2,4-diamines as potent inhibitors against CDK2 and CDK9.

Authors:  Jiadi Gao; Cheng Fang; Zhiyan Xiao; Li Huang; Chin-Ho Chen; Li-Ting Wang; Kuo-Hsiung Lee
Journal:  Medchemcomm       Date:  2015-03-01       Impact factor: 3.597

8.  Recruitment of cdk9 to the immediate-early viral transcriptosomes during human cytomegalovirus infection requires efficient binding to cyclin T1, a threshold level of IE2 86, and active transcription.

Authors:  Anokhi J Kapasi; Charles L Clark; Karen Tran; Deborah H Spector
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

9.  Potent anti-tumor activity of a macrocycle-quinoxalinone class pan-Cdk inhibitor in vitro and in vivo.

Authors:  Hiroshi Hirai; Ikuko Takahashi-Suziki; Toshiyasu Shimomura; Kazuhiro Fukasawa; Takumitsu Machida; Toru Takaki; Makiko Kobayashi; Tomohiro Eguchi; Hiroko Oki; Tsuyoshi Arai; Koji Ichikawa; Shinichi Hasako; Tsutomu Kodera; Nobuhiko Kawanishi; Yoko Nakatsuru; Hidehito Kotani; Yoshikazu Iwasawa
Journal:  Invest New Drugs       Date:  2010-01-19       Impact factor: 3.850

10.  The Aspergillus nidulans npkA gene encodes a Cdc2-related kinase that genetically interacts with the UvsBATR kinase.

Authors:  Marcia R V Z Kress Fagundes; Joel Fernandes Lima; Marcela Savoldi; Iran Malavazi; Roy E Larson; Maria H S Goldman; Gustavo H Goldman
Journal:  Genetics       Date:  2004-08       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.